Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Recurrent venous thrombosis in an adolescent male with CBS mutation and persistent antiphospholipid antibody
Yuebing Wang1, Ru Li1, Chun Li2
1Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Beijing, China.
Insights
Genetic mutations causing high homocysteine (Hcy) levels and antiphospholipid antibodies contributed to a teen
Area of Science:
- Cardiovascular Medicine
- Genetics
- Hematology
Background:
- Elevated plasma homocysteine (Hcy) levels are associated with endothelial dysfunction, impaired thrombolysis, and increased thrombosis risk.
- Genetic mutations in the cystathionine β-synthase (CBS) gene reduce enzymatic activity, leading to hyperhomocysteinemia (HHcy).
- Antiphospholipid antibodies (aPL) are implicated in thrombotic events, often in conjunction with other risk factors.
Purpose of the Study:
- To present a case report of a young male with recurrent deep vein thrombosis (DVT).
- To investigate the underlying causes of severe DVT in a 15-year-old male.
- To explore the interplay of genetic, metabolic, and autoimmune factors in a thrombophilic condition.
Main Methods:
- Case presentation of a 15-year-old male with recurrent lower extremity DVT.
- Laboratory evaluation including plasma homocysteine levels.
- Genetic analysis for mutations in the cystathionine β-synthase (CBS) gene.
- Testing for antiphospholipid antibodies.
Main Results:
- The patient presented with recurrent, severe deep vein thrombosis (DVT) of the lower extremities.
- Laboratory tests revealed elevated homocysteine levels.
- Genetic analysis identified mutations in the CBS gene.
- Persistent positivity for antiphospholipid antibodies was observed.
Conclusions:
- The case highlights a genetic predisposition to thrombosis due to CBS gene mutations and hyperhomocysteinemia.
- The co-occurrence of antiphospholipid antibodies suggests a multifactorial thrombophilic condition.
- This case underscores the importance of investigating multiple contributing factors in young patients with recurrent DVT.
Abstract:
Homocysteine (Hcy) contributes to endothelial dysfunction and impaired thrombolysis, and genetic polymorphisms that elevate plasma Hcy concentrations have been linked to an increased risk of thrombosis. Notably, mutations in the cystathionine β-synthase (CBS) gene, which reduce enzymatic activity, are a well-established cause of hyperhomocysteinemia (HHcy). This case report presents a 15-year-old male with recurrent, severe deep vein thrombosis (DVT) of the lower extremities, accompanied by persistent positivity for antiphospholipid antibodies. Laboratory evaluation revealed elevated homocysteine levels and mutations in the CBS gene, highlighting an underlying genetic predisposition. The persistent presence of antiphospholipid antibodies further underscores the multifactorial nature of his thrombophilic condition, involving genetic, metabolic, and autoimmune mechanisms.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

